DRKS00012447已完成不适用
ongterm follow-up of a controlled randomized trial of single-port laparoscopic cholecystecomy vs. multiport laparoscopic cholecystecomy
Charité Campus Charité Mitte0 个研究点目标入组 200 人开始时间: 2017年5月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •Colecystectomy as primary operation, Patients older than 18 years od Age, Participation of the previous controlled randomized trial comparing the single-port and multiport laparoscopic cholecystectomy.
排除标准
- •Not self-sufficient patients, patients under 18 years, patient's desire
研究者
相似试验
尚未招募
不适用
ong term follow up of randomised clinical trial on total joint arthroplasty or trapeziectomie for trapeziometacarpal osteoarthritistrapeziometacarpal osteoarthritiscarpometacarpal osteoarthritis10023213NL-OMON42533Isala Klinieken55
已完成
不适用
A follow-up of the Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP) and their children: REVAMP Extendanaemiairon deficiencychild developmentChild growthMaternal depressionInfectionBlood - AnaemiaPublic Health - Other public healthACTRN12620000382976niversity of Malawi, College of Medicine862
进行中（未招募）
不适用
ong-term follow-up of breast cancer survivors: A randomized controlled studyBreast cancer survivorshipBreast cancerCancerISRCTN15403211Koo Foundation Sun Yat-Sen Cancer Center902
尚未招募
不适用
Mid-term follow-up of a randomized controlled trial comparing ultrasound-guided double percutaneous needling versus high-energy extracorporeal shockwave therapy in the treatment of calcific tendinitis of the rotator cuff.NL-OMON51922Spaarne Gasthuis81
已完成
3 期
REGiM: Prolonged treatment with darbepoetin alpha (EPO), with/without recombinant human granulocyte colony stimulating factor (G-CSF), versus best supportive care in patients with low-risk myelodysplastic syndromes (MDS)Topic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (acute myeloid)Myelodysplastic syndromesCancerISRCTN65652441Barts and The London NHS Trust (UK)1,200